REACT: a randomized trial to assess the efficacy and safety of clazosentan for preventing clinical deterioration due to delayed cerebral ischemia after aneurysmal subarachnoid hemorrhageStephan A. Mayer, Manfred Westphal, Thanh N. Nguyen et al.|Journal of neurosurgery|2024Cited by 31